SM
ALXA

Sabby Management’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

Sabby Management’s Portfolio ALXA Stock Details ALXA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-2,040
Closed -$304 – 345
2014
Q4 		$304 Hold
2,040
– – 0.01% 202
2014
Q3 		$475 Hold
2,040
– – 0.02% 184
2014
Q2 		$932K Hold
2,040
– – 0.04% 158
2014
Q1 		$904K Hold
2,040
– – 0.05% 140
2013
Q4 		$965K Hold
2,040
– – 0.06% 124
2013
Q3 		$1.04M Sell
2,040
-10
-0.5% -$47 0.07% 120
2013
Q2 		$890K Buy
+2,050
New +$9.29K 0.06% 124

Other funds holding ALXA

LPA
Lansdowne Partners Austria Vienna, Austria $29M AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
CLOS
Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return
HHMI
Howard Hughes Medical Institute Chevy Chase, Maryland $416M AUM 13.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return